Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Short Interest Update

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) saw a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 13,500 shares, a decrease of 19.2% from the April 30th total of 16,700 shares. Based on an average daily volume of 596,100 shares, the short-interest ratio is presently 0.0 days.

Ono Pharmaceutical Trading Up 2.4%

Ono Pharmaceutical stock opened at $3.60 on Monday. The stock has a fifty day moving average of $3.70 and a 200 day moving average of $3.60. Ono Pharmaceutical has a one year low of $3.21 and a one year high of $5.20.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.